BUZZ0.370%
as of Sep 2
TGTX
GrowthTG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody.
Close · 3M
+54.86%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals8
Win rate88% (7/8)
Avg buy return+9.33%
BUZZ · Weight increase · 2d
weight 0.330% → 0.370% (+0.040 pp)·stock down 0.1% in the 30 days before
Aug 24·entry $56.01·now $56.71Fresh
+1.25%
since Aug 24
BUZZ · Weight decrease · 2d
weight 0.370% → 0.340% (-0.030 pp)·stock down 15.0% in the 30 days before
Aug 13·entry $47.94·now $56.71
+18.29%
since Aug 13
BUZZ · Weight decrease · 3d
weight 0.450% → 0.360% (-0.090 pp)·stock down 13.4% in the 30 days before
Aug 3·entry $46.17·now $56.71
+22.83%
since Aug 3
BUZZ · Weight decrease · 2d
weight 0.450% → 0.410% (-0.040 pp)·stock down 2.8% in the 30 days before
Jul 31·entry $52.03·now $56.71
+8.99%
since Jul 31
BUZZ · Weight increase · 2d
weight 0.400% → 0.450% (+0.050 pp)·stock up 4.6% in the 30 days before
Jul 24·entry $56.04·now $56.71Fresh
+1.20%
since Jul 24
BUZZ · Weight decrease · 3d
weight 0.430% → 0.400% (-0.030 pp)·stock down 3.2% in the 30 days before
Jul 22·entry $52.68·now $56.71
+7.65%
since Jul 22
BUZZ · Weight decrease · 2d
weight 0.430% → 0.410% (-0.020 pp)·stock up 1.4% in the 30 days before
Jul 21·entry $53.95·now $56.71
+5.12%
since Jul 21
BUZZ · Weight decrease · 2d
weight 0.460% → 0.440% (-0.020 pp)·stock up 18.0% in the 30 days before
Jul 13·entry $55.01·now $56.71
+3.09%
since Jul 13
BUZZ · Weight increase · 2d
weight 0.420% → 0.460% (+0.040 pp)·stock up 43.1% in the 30 days before
Jul 7·entry $58.06·now $56.71Fresh
-2.33%
since Jul 7
BUZZ · Weight decrease · 2d
weight 0.450% → 0.420% (-0.030 pp)·stock up 44.8% in the 30 days before
Jun 30·entry $54.94·now $56.71
+3.22%
since Jun 30
BUZZ · Weight increase · 3d
weight 0.400% → 0.430% (+0.030 pp)·stock up 37.9% in the 30 days before
Jun 24·entry $53.60·now $56.71Drifting
+5.80%
since Jun 24
BUZZ · Weight increase · 2d
weight 0.400% → 0.420% (+0.020 pp)·stock up 37.5% in the 30 days before
Jun 23·entry $53.94·now $56.71Drifting
+5.14%
since Jun 23
BUZZ · Accumulation · 5d
weight 0.360% → 0.470% (+0.110 pp)·stock up 30.4% in the 30 days before
Jun 17·entry $51.50·now $56.71Chased
+10.12%
since Jun 17
BUZZ · Weight increase · 2d
weight 0.360% → 0.440% (+0.080 pp)·stock up 8.1% in the 30 days before
Jun 10·entry $46.62·now $56.71Chased
+21.64%
since Jun 10
BUZZ · Weight decrease · 3d
weight 0.350% → 0.310% (-0.040 pp)·stock up 13.0% in the 30 days before
May 29·entry $37.94·now $56.71
+49.47%
since May 29
BUZZ · Weight decrease · 2d
weight 0.350% → 0.330% (-0.020 pp)·stock up 12.3% in the 30 days before
May 28·entry $38.82·now $56.71
+46.08%
since May 28
BUZZ · Weight decrease · 2d
weight 0.370% → 0.350% (-0.020 pp)·stock up 2.4% in the 30 days before
May 21·entry $39.24·now $56.71
+44.52%
since May 21
BUZZ · Weight increase · 2d
weight 0.340% → 0.400% (+0.060 pp)·stock up 25.8% in the 30 days before
May 7·entry $43.02·now $56.71Chased
+31.81%
since May 7
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.